60 Participants Needed

Exercise Training for Cardiovascular Disease

AM
Overseen ByAbeer M Mohamed, MD, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial involves exercise training, you should consult with your doctor to ensure your medications are compatible with the exercise program.

What data supports the effectiveness of the treatment Exercise training for cardiovascular disease?

Research shows that exercise training can improve heart health by increasing exercise tolerance, controlling risk factors, and potentially influencing heart disease progression. It also helps reduce depression and anxiety, leading to a better quality of life for heart patients.12345

Is exercise training safe for people with cardiovascular disease?

Exercise training is generally safe for people with cardiovascular disease, with serious complications being exceptionally rare. Studies show that it can improve exercise capacity and quality of life, and while some nonfatal cardiac events have occurred, there were no fatalities reported.678910

How is exercise training different from other treatments for cardiovascular disease?

Exercise training is unique because it focuses on improving heart health through physical activity rather than medication or surgery. It involves a variety of exercises tailored to individual needs, aiming to enhance endurance, strength, and flexibility, which can improve quality of life and potentially reduce the risk of future heart problems.211121314

What is the purpose of this trial?

The development of type II diabetes (T2D) is strongly associated with obesity and both are well-established risk factors for cardiovascular disease. Knowing that vascular dysfunction is an early event in the development of cardiovascular disease in obese diabetic (OB-T2D) patients, The investigators set their long-term goal to define molecular mechanisms of vascular dysfunction and corrective strategies that target these mechanisms such as physical activity and weight loss. The investigators recently discovered that human adipose tissues release extracellular vesicles (adiposomes) that are efficiently captured by endothelial cells. Adiposomes are known to carry bioactive cargos such as proteins and micro RNAs; however, their lipid content has not been studied nor has their ability to transfer their lipid cargo to endothelial cells. In the current application, the investigators propose to investigate the role of adiposomes in communicating the unhealthy milieu, mainly dysregulated lipids, to endothelial cells in OB-T2D subjects. On top of these lipid species that the investigators propose to be carried by adiposomes are glycosphingolipids (GSLs). These lipids originate from the glycosylation of ceramides, a chemical process that is upregulated in the presence of inflammation and high glucose levels. Preliminary findings showed that in endothelial cells, GSL-rich adiposomes disturb plasma membrane structure and subsequently induce endothelial dysfunction. Moreover, the investigators found that preconditioning endothelial cells with high shear stress (which is an exercise mimetic) protected endothelial cells from the detrimental effects induced by adiposomes. Therefore, the central hypothesis is that adipose tissues in OB-T2D patients release GSL-loaded adiposomes that induce vascular endothelial dysfunction. The researchers propose that exercise and weight loss interventions (bariatric surgery) will restore adipose tissue homeostasis, reduce GSL-loaded adiposomes, and subsequently alleviate vascular risk in OB-T2D patients. The investigators will test the hypotheses by pursuing the following aims: aim 1: Investigate the role of GSL-rich adiposomes in the pathogenesis of endothelial dysfunction in OB-T2D adults; aim 2: Test the effectiveness of exercise training in reducing adiposome-mediated effects on vascular function; and aim 3: Examine changes in adiposome/caveolae axis following metabolic surgery and their association with vascular function.

Research Team

AM

Abeer M Mohamed, MD, PhD

Principal Investigator

University of Illinois at Chicago

Eligibility Criteria

This trial is for adults aged 18-50 with obesity (BMI ≥ 35 kg/m2) and type II diabetes, who are not pregnant, can exercise moderately, and have no chronic heart, liver, kidney diseases or cancer. Smokers, drug/alcohol abusers, non-English speakers and those allergic to lidocaine cannot join.

Inclusion Criteria

I am diabetic or my fasting blood sugar is 126 mg/dL or higher.
My BMI is 35 or higher.
I am medically cleared for moderate exercise.
See 1 more

Exclusion Criteria

Current smokers
Currently abusing alcohol or drugs
I have a chronic condition like heart, liver, kidney disease, an autoimmune disease, or another cancer.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Exercise Training

Participants undergo aerobic exercise training for 12 weeks, 3 times per week, 60 minutes per session

12 weeks
36 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Metabolic Surgery

Participants may undergo metabolic surgery to examine changes in adiposome/caveolae axis and their association with vascular function

Treatment Details

Interventions

  • Exercise training
Trial Overview The study investigates how fat cells in obese diabetic patients affect blood vessel function by releasing 'adiposomes' that may carry harmful lipids. It will test if exercise training or weight loss surgery can reduce these effects and improve vascular health.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise trainingExperimental Treatment1 Intervention
Aerobic exercise training for 12 weeks, 3 times per week, 60 minutes per session.
Group II: Control (standards of care)Active Control1 Intervention
This arm will receive brochures for healthy lifestyle recommendations. No intervention will be conducted.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

The HF-ACTION trial aims to determine if exercise training can reduce all-cause mortality and hospitalization in patients with heart failure, involving 36 supervised sessions followed by home-based exercise over a 4-year period.
Exercise training is a low-cost and accessible intervention that may improve health outcomes for heart failure patients, with various physiological and quality-of-life measures being assessed throughout the study.
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.Whellan, DJ., O'Connor, CM., Lee, KL., et al.[2007]
Regular exercise significantly benefits patients with heart disease by improving exercise tolerance, controlling risk factors, and potentially influencing the progression of coronary artery disease.
Patients should follow physician-guided exercise plans that include dynamic endurance activities and moderate-intensity circuit weight training, with a recommended duration of 2 to 3 hours per week, while high-risk patients should exercise at lower intensities.
[Heart patient and sports].Niederhauser, HU.[2008]
A patient with Spontaneous Coronary Artery Dissection underwent 21 sessions of cardiac rehabilitation, which led to significant improvements in aerobic capacity, flexibility, and grip strength.
The rehabilitation program helped maintain stable anthropometric values, indicating that physical exercise can be an effective complementary therapy alongside medication for cardiac patients.
Influence of cardiac rehabilitation in Primigravida with spontaneous coronary artery dissection during postpartum.Pinto, Mde C., Camargo, RC., Filho, JC., et al.[2021]

References

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. [2007]
[Heart patient and sports]. [2008]
Influence of cardiac rehabilitation in Primigravida with spontaneous coronary artery dissection during postpartum. [2021]
Exercise in cardiovascular diseases. [2022]
Exercise And Heart Failure: Advancing Knowledge And Improving Care. [2018]
Safety of exercise training for cardiac patients: results of the French registry of complications during cardiac rehabilitation. [2022]
[Effects of continuous physical training on exercise tolerance and left ventricular myocardial function in patients with heart failure]. [2019]
Exercise training in chronic heart failure: mechanisms and therapies. [2022]
[Results of in-patient rehabilitation after myocardial infarction]. [2006]
[Best of functional evaluation and cardiac rehabilitation in 2005]. [2009]
Exercise following myocardial infarction. Current recommendations. [2018]
[Exercise training in the therapy of heart diseases: Current evidence and future options]. [2018]
Exercise training in coronary artery disease. [2007]
Types of exercise. Arm-leg and static-dynamic. [2007]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security